The Safety/Efficacy Study of Human Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife®-LDP) for Lumbar Discogenic Pain

PHASE1RecruitingINTERVENTIONAL

Enrollment

242

Participants

Timeline

Start Date

August 15, 2019

Primary Completion Date

December 31, 2025

Study Completion Date

June 30, 2026

Conditions

Lumbar Discogenic Pain

Interventions

BIOLOGICAL

human umbilical cord mesenchymal stem cell

2\*10\^7

Trial Locations (1)

RECRUITING

Xuanwu Hospital Capital Medical University, Beijing

All Listed Sponsors

lead

Sclnow Biotechnology Co., Ltd.

INDUSTRY